Cellusion Inc.

The volume of $100m-plus venture capital mega-rounds continues to build throughout 2023 after a slow start, but a wider look at the biopharmaceutical VC landscape illustrates the valley of death that

The Japanese government has started a new funding project for pharma bioventures in the country with a new JPY50bn ($420m) budget, aiming to strengthen the domestic ecosystem for drug and vaccine deve